Llwytho...
Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
Modifying the entry of pyruvate into mitochondria may provide a unique approach to treat metabolic disease. The pharmacology of a new class of insulin sensitizers directed against a newly identified mitochondrial target may treat many aspects of nonalcoholic steatohepatitis, including fibrosis. This...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Hepatol Commun |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721453/ https://ncbi.nlm.nih.gov/pubmed/29404453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1036 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|